Limits...
pncA Mutations in the Specimens from Extrapulmonary Tuberculosis.

Lee J, Yun YJ, Kqueen CY, Lee JH, Kim HY, Kim YR, Kook YH, Lee KH - Tuberc Respir Dis (Seoul) (2012)

Bottom Line: Pyrazinamide (PZA) is an effective antitubercular drug that becomes toxic to Mycobacterium tuberculosis when converted to pyrazinoic acid by pyrazinamidase (PZase), encoded by mycobacterial pncA.The mutation at position 169 results in substitution of aspartic acid for histidine, a possible allelic variation of M. bovis that have intrinsic PZA resistance.A potential implication of pncA allelic variation at 169 might be suggested as a rapid diagnostic test for M. bovis infection or Bacille Calmette-Guérin (BCG) reactivation.

View Article: PubMed Central - PubMed

Affiliation: Jeju National University School of Medicine, Jeju, Korea.

ABSTRACT

Background: Pyrazinamide (PZA) is an effective antitubercular drug that becomes toxic to Mycobacterium tuberculosis when converted to pyrazinoic acid by pyrazinamidase (PZase), encoded by mycobacterial pncA. A strong association was noted between the loss of PZase activity and PZA resistance. The causative organisms in extrapulmonary tuberculosis are rarely cultured and isolated. To detect pncA mutations in specimens from extrapulmonary tuberculosis as confirmative diagnosis of mycobacterial infection and alternative susceptibility test to PZA.

Methods: Specimens were collected from clinically proven extrapulmonary tuberculosis. pncA was sequenced and compared with wild-type pncA.

Results: pncA from 30 specimens from 23 donors were successfully amplified (56.6% in specimens, 59% in donors). Six mutations in pncA were detected (20.0% in amplified specimens, 26.1% in specimen donors) at nucleotide positions of 169, 248 and 419. The mutation at position 169 results in substitution of aspartic acid for histidine, a possible allelic variation of M. bovis that have intrinsic PZA resistance. The mutation at position 248 changes proline into arginine and that at position 419, arginine into histidine.

Conclusion: DNA-based diagnosis using pncA may be simultaneously useful for the early diagnosis of mycobacterial infection and the rapid susceptibility to PZA in extrapulmonary tuberculosis. A potential implication of pncA allelic variation at 169 might be suggested as a rapid diagnostic test for M. bovis infection or Bacille Calmette-Guérin (BCG) reactivation.

No MeSH data available.


Related in: MedlinePlus

Genomic DNA sequences of pncA encoding pyrazinamidase in Mycobacterium tuberculosis. The mutation spots in pncA in pyrazinamide (PZA)-resistant isolates previously reported in the reference 6-8,11 among South Koreans were underlined. Three mutations from extrapulmonary tuberculosis detected in this study were marked in bold. Nucleotides were numbered from start codon  of pncA. This figure is modified from those of the reference7,11.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC3475457&req=5

Figure 1: Genomic DNA sequences of pncA encoding pyrazinamidase in Mycobacterium tuberculosis. The mutation spots in pncA in pyrazinamide (PZA)-resistant isolates previously reported in the reference 6-8,11 among South Koreans were underlined. Three mutations from extrapulmonary tuberculosis detected in this study were marked in bold. Nucleotides were numbered from start codon of pncA. This figure is modified from those of the reference7,11.

Mentions: All the mutations showed single point mutations where a single nucleotide was changed, subsequently translating into a different amino acid in PZase protein. The mutations were detected at nucleotide positions of 169, 248, and 419 from the start codon (ATG) of pncA. The mutation at position 169 detected in four specimens was identical, a change of C to G, which caused a change from histidine (CAC) to aspartic acid (GAC) at amino acid position 57 of PZase. The mutation at nucleotide position 248 detected in one specimen changes amino acid 83 from proline (CCC) to arginine (CGC). One specimen showed a mutation at nucleotide 419, which changes arginine 140 (CGC) into histidine (CAC) (Figure 1).


pncA Mutations in the Specimens from Extrapulmonary Tuberculosis.

Lee J, Yun YJ, Kqueen CY, Lee JH, Kim HY, Kim YR, Kook YH, Lee KH - Tuberc Respir Dis (Seoul) (2012)

Genomic DNA sequences of pncA encoding pyrazinamidase in Mycobacterium tuberculosis. The mutation spots in pncA in pyrazinamide (PZA)-resistant isolates previously reported in the reference 6-8,11 among South Koreans were underlined. Three mutations from extrapulmonary tuberculosis detected in this study were marked in bold. Nucleotides were numbered from start codon  of pncA. This figure is modified from those of the reference7,11.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC3475457&req=5

Figure 1: Genomic DNA sequences of pncA encoding pyrazinamidase in Mycobacterium tuberculosis. The mutation spots in pncA in pyrazinamide (PZA)-resistant isolates previously reported in the reference 6-8,11 among South Koreans were underlined. Three mutations from extrapulmonary tuberculosis detected in this study were marked in bold. Nucleotides were numbered from start codon of pncA. This figure is modified from those of the reference7,11.
Mentions: All the mutations showed single point mutations where a single nucleotide was changed, subsequently translating into a different amino acid in PZase protein. The mutations were detected at nucleotide positions of 169, 248, and 419 from the start codon (ATG) of pncA. The mutation at position 169 detected in four specimens was identical, a change of C to G, which caused a change from histidine (CAC) to aspartic acid (GAC) at amino acid position 57 of PZase. The mutation at nucleotide position 248 detected in one specimen changes amino acid 83 from proline (CCC) to arginine (CGC). One specimen showed a mutation at nucleotide 419, which changes arginine 140 (CGC) into histidine (CAC) (Figure 1).

Bottom Line: Pyrazinamide (PZA) is an effective antitubercular drug that becomes toxic to Mycobacterium tuberculosis when converted to pyrazinoic acid by pyrazinamidase (PZase), encoded by mycobacterial pncA.The mutation at position 169 results in substitution of aspartic acid for histidine, a possible allelic variation of M. bovis that have intrinsic PZA resistance.A potential implication of pncA allelic variation at 169 might be suggested as a rapid diagnostic test for M. bovis infection or Bacille Calmette-Guérin (BCG) reactivation.

View Article: PubMed Central - PubMed

Affiliation: Jeju National University School of Medicine, Jeju, Korea.

ABSTRACT

Background: Pyrazinamide (PZA) is an effective antitubercular drug that becomes toxic to Mycobacterium tuberculosis when converted to pyrazinoic acid by pyrazinamidase (PZase), encoded by mycobacterial pncA. A strong association was noted between the loss of PZase activity and PZA resistance. The causative organisms in extrapulmonary tuberculosis are rarely cultured and isolated. To detect pncA mutations in specimens from extrapulmonary tuberculosis as confirmative diagnosis of mycobacterial infection and alternative susceptibility test to PZA.

Methods: Specimens were collected from clinically proven extrapulmonary tuberculosis. pncA was sequenced and compared with wild-type pncA.

Results: pncA from 30 specimens from 23 donors were successfully amplified (56.6% in specimens, 59% in donors). Six mutations in pncA were detected (20.0% in amplified specimens, 26.1% in specimen donors) at nucleotide positions of 169, 248 and 419. The mutation at position 169 results in substitution of aspartic acid for histidine, a possible allelic variation of M. bovis that have intrinsic PZA resistance. The mutation at position 248 changes proline into arginine and that at position 419, arginine into histidine.

Conclusion: DNA-based diagnosis using pncA may be simultaneously useful for the early diagnosis of mycobacterial infection and the rapid susceptibility to PZA in extrapulmonary tuberculosis. A potential implication of pncA allelic variation at 169 might be suggested as a rapid diagnostic test for M. bovis infection or Bacille Calmette-Guérin (BCG) reactivation.

No MeSH data available.


Related in: MedlinePlus